University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

Salmeterol/fluticasone stable-dose treatment compared with formoterol/budesonide adjustable maintenance dosing : impact on health-related quality of life

dc.contributor.authorPrice, David Brendan
dc.contributor.authorWilliams, A. E.
dc.contributor.authorYoxall, S.
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.date.accessioned2020-06-22T16:25:01Z
dc.date.available2020-06-22T16:25:01Z
dc.date.issued2007-07-04
dc.descriptionAcknowledgements This study was funded by GlaxoSmithKline Research and Development Limited, Greenford, UK.en
dc.description.statusPeer revieweden
dc.format.extent7
dc.format.extent596962
dc.identifier195707
dc.identifier20b13ac9-a97a-4dd1-8987-a9b2202f2da9
dc.identifier34548525328
dc.identifier.citationPrice, D B, Williams, A E & Yoxall, S 2007, 'Salmeterol/fluticasone stable-dose treatment compared with formoterol/budesonide adjustable maintenance dosing : impact on health-related quality of life', Respiratory Research, vol. 8, 46. https://doi.org/10.1186/1465-9921-8-46en
dc.identifier.doi10.1186/1465-9921-8-46
dc.identifier.issn1465-9921
dc.identifier.otheraberdeen_publication: 14793
dc.identifier.urihttps://hdl.handle.net/2164/14553
dc.identifier.vol8en
dc.language.isoeng
dc.relation.ispartofRespiratory Researchen
dc.subjectAsthmaen
dc.subjectAsthma controlen
dc.subjectMinimal Important Differenceen
dc.subjectBeclomethasone Dipropionateen
dc.subjectExacerbation Rateen
dc.subjectR Medicineen
dc.subject.lccRen
dc.titleSalmeterol/fluticasone stable-dose treatment compared with formoterol/budesonide adjustable maintenance dosing : impact on health-related quality of lifeen
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Price_et_al_RR_SalmeterolFluticasoneStable_VoR.pdf
Size:
582.97 KB
Format:
Adobe Portable Document Format

Collections